Cite
HARVARD Citation
Luther, A. et al. (2020). P134: Does the use of oncotype DX testing in patients with breast cancer aged 65 and over affect management of adjuvant chemotherapy?. European journal of surgical oncology. 46 (6), pp. e46-. [Online].